Abstract Structure-based drug design uses three-dimensional geometric information of macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric …
This work introduces a diffusion model for molecule generation in 3D that is equivariant to Euclidean transformations. Our E (3) Equivariant Diffusion Model (EDM) learns to denoise a …
Abstract Structure-based drug design (SBDD) aims to design small-molecule ligands that bind with high affinity and specificity to pre-determined protein targets. Generative SBDD …
G Chou, Y Bahat, F Heide - Proceedings of the IEEE/CVF …, 2023 - openaccess.thecvf.com
Probabilistic diffusion models have achieved state-of-the-art results for image synthesis, inpainting, and text-to-image tasks. However, they are still in the early stages of generating …
O Zhang, J Zhang, J Jin, X Zhang, RL Hu… - Nature Machine …, 2023 - nature.com
Most molecular generative models based on artificial intelligence for de novo drug design are ligand-centric and do not consider the detailed three-dimensional geometries of protein …
Rich data and powerful machine learning models allow us to design drugs for a specific protein target\textit {in silico}. Recently, the inclusion of 3D structures during targeted drug …
D Soydaner - Neural Computing and Applications, 2022 - Springer
A long time ago in the machine learning literature, the idea of incorporating a mechanism inspired by the human visual system into neural networks was introduced. This idea is …
A fundamental problem in drug discovery is to design molecules that bind to specific proteins. To tackle this problem using machine learning methods, here we propose a novel …
Generating molecules that bind to specific proteins is an important but challenging task in drug discovery. Most previous works typically generate atoms autoregressively, with element …